Genprex annual revenue
2016
2017
2018
2020
2021
2022
2023
2024
2025
Genprex reported $0 in revenue for fiscal 2025.
View full Genprex company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | — | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $0 | $0 | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2019 | 2019-03-31 | $0 | $0 | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | — | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | — | — |
| Q1 2017 | 2017-03-31 | $0 | — | — |
| Q3 2016 | 2016-09-30 | $0 | — | — |
Genprex's latest reported quarter, Q2 2026, generated $0 in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Genprex source filings ↗